Ute Koeber
About Ute Koeber
Ute Koeber is a scientist currently working at Asklepios BioPharmaceutical, Inc. in Edinburgh, Scotland, with a strong academic background in molecular life sciences and regenerative biology.
Work at Asklepios BioPharmaceutical
Ute Koeber has been employed at Asklepios BioPharmaceutical, Inc. (AskBio) since 2021, serving as a Scientist. Her role involves conducting research and development in the field of biopharmaceuticals. AskBio is known for its innovative approaches in gene therapy and regenerative medicine, and Koeber contributes to advancing these initiatives.
Education and Expertise
Ute Koeber holds a Doctor of Philosophy (PhD) from The University of Edinburgh, where she focused on promoter development from 2016 to 2020. Prior to this, she earned a Master of Science (MS) in Molecular Life Science from Friedrich Schiller University Jena, completing her studies from 2013 to 2016. She also holds a Bachelor of Science (BS) in Biochemistry from the University of Tuebingen, which she completed from 2010 to 2013. Additionally, she studied at Harvard University in the Department of Stem Cell and Regenerative Biology for four months in 2014-2015.
Background
Ute Koeber began her academic journey in biochemistry at the University of Tuebingen, where she obtained her Bachelor of Science degree. She then pursued a Master of Science at Friedrich Schiller University Jena, followed by a PhD at The University of Edinburgh. Her research experience includes a position as a Research Assistant at the Fritz Lipmann Institute (FLI) Leibniz Institute on Aging in Jena, Germany, for four months in 2016. She also interned at Biontex Laboratories GmbH in Munich for five months in 2010.
Research Experience
Throughout her career, Ute Koeber has gained significant research experience in various prestigious institutions. She worked as a Research Assistant at the Fritz Lipmann Institute in 2016, where she contributed to aging research. Additionally, her time at Harvard University in the Rubin Lab provided her with exposure to stem cell and regenerative biology, enhancing her expertise in these fields.